Summary: In a pilot randomised trial in Chinese Americans with type 2 diabetes, a culturally and linguistically tailored education and support programme improved diabetes self-efficacy, reduced diabetes distress, and increased healthy-diet adherence compared with a waitlist control.
PICO Summary
| Element | Detail |
|---|---|
| Population | 60 Chinese Americans (aged 18–70) with type 2 diabetes and HbA1c ≥7%, mostly with limited English proficiency; pilot RCT (secondary analysis), New York City. |
| Intervention | Culturally and linguistically tailored CARE programme: two short educational videos weekly for 12 weeks via WeChat, plus community-health-worker support calls. |
| Comparison | Waitlist control (n=30). |
| Outcome | The intervention improved self-efficacy at 3 months (estimated difference 8.47; p=0.02), reduced diabetes distress at 6 months (-0.43; p=0.009), and improved healthy-diet adherence at both 3 and 6 months (about 1.6 points; p=0.02). |
Culturally tailored CARE programme in T2D
Pilot RCT · type 2 diabetes · 6 months
A culturally and linguistically tailored mHealth plus community-health-worker programme significantly improved self-efficacy, diabetes distress, and diet adherence versus waitlist. Promising pilot data awaiting a larger trial powered for glycaemic outcomes.
Expert Commentary
This is a thoughtful health-equity trial addressing a population that faces real linguistic, cultural, and access barriers to evidence-based diabetes care, and its pragmatic delivery through a widely used messaging app plus community health workers is well suited to that context. The psychosocial and behavioural gains, greater self-efficacy, lower diabetes distress, and better dietary adherence, are meaningful because these are often the mediators of sustained self-management, and tailoring content to language and culture is a sensible way to reach groups that generic programmes miss. I would read it as promising rather than definitive, exactly as the authors frame it. This is a pilot with only 60 participants, the outcomes reported here are self-reported secondary endpoints from a study whose primary interest was HbA1c, and a behavioural intervention cannot be blinded, so expectation effects on self-report are possible, and durability beyond six months is untested. Can I use this with my patients? Yes, in spirit. It reinforces offering culturally and linguistically matched education and community-health-worker support to patients from underserved language groups, while I treat the specific programme as a model awaiting confirmation in a larger trial powered for glycaemic outcomes.
References
Liu J, Cao J, Shi Y, et al. A culturally and linguistically tailored intervention to improve diabetes-related outcomes in Chinese Americans with type 2 diabetes: pilot randomized controlled trial. JMIR Mhealth Uhealth. 2025;13:e78036. doi:10.2196/78036